Disclosure of shareholdings in accordance with articles 20 and 21 SESTA
Liestal, Switzerland, August 23, 2011 - Santhera Pharmaceuticals (SWX: SANN) was informed by Baker Bros. Advisors, LLC, 667 Madison Avenue, New York, NY 10065, USA, that
- Baker Brothers Life Sciences, L.P.
- Baker Bros. Advisors, LLC
hold a total of 190'792 registered shares of Santhera Pharmaceuticals Holding AG, representing 5.21% of the voting rights of the shares registered in the Commercial Register. Baker Bros. Advisors, LLC is the investment manager of Baker Brothers Life Sciences, L.P. Contact person at Baker Bros. Advisors, LLC is Leo Kirby (phone/fax: +1 212 339 5633/ +1 212 339 5688).
Baker Bros. Advisors, LLC is a privately owned investment manager primarily investing in healthcare stocks across micro- to mid-market capitalizations. The firm is a growth investor seeking companies with innovative products that have undervalued, mispriced current share prices. Baker Bros. Advisors was founded in 2000 and is based in New York, NY, USA.
* * *
For further information, contact
Thomas Staffelbach, Head Public & Investor Relations
Phone +41 (0)61 906 89 47
thomas.staffelbach@santhera.com
